Currently this content is only available in English.
Dieser Inhalt ist momentan nur auf Englisch verfügbar.
Die Medgate Kids Line liefert schnell und unkompliziert medizinischen Rat, wenn es Ihrem Kind nicht gut geht. Rund um die Uhr steht Ihnen das medizinische Team unseres Partners Medgate telefonisch zur Verfügung.
0900 712 712 (3.23 CHF / Min.)
nur über private Festnetz- oder Handynummern
0900 712 713 (3.23 CHF / Min.)
für Anrufe von Prepaid-Handys
Für Business-Anschlüsse: 0800 444 333 (Kosten werden über Krankenversicherung abgerechnet)
Bei Notfällen im Ausland rufen Sie die Notfallnummer Ihrer Krankenkasse an. Diese finden Sie jeweils auf Ihrer Krankenkassenkarte.
Notfallnummern
Beratungstelefon für Kinder- und Jugendnotfälle
Die Medgate Kids Line liefert schnell und unkompliziert medizinischen Rat, wenn es Ihrem Kind nicht gut geht. Rund um die Uhr steht Ihnen das medizinische Team unseres Partners Medgate telefonisch zur Verfügung.
0900 712 712 (3.23 CHF / Min.)
Festnetz und Handy-Abo
0900 712 713 (3.23 CHF / Min.)
Prepaid-Handys
Für Business-Anschlüsse: 0800 444 333 (Kosten werden über Krankenversicherung abgerechnet)
Für Notfälle im Ausland: Rufen Sie die Notfallnummer Ihrer Krankenkasse an. Diese finden Sie jeweils auf Ihrer Krankenkassenkarte.
Wichtige Notfallnummern
- 144 Ambulanz
- 145 Tox Info Suisse (Vergiftungen)
- 117 Polizei
- 118 Feuerwehr
Kontakt Box
Kontakt
Zu welchem Thema möchten Sie uns kontaktieren?
Für Lob oder Tadel nutzen Sie bitte das Feedback-Formular.
Terminvereinbarung sind nicht über das Kontaktformular möglich. Für Terminvereinbarungen und -verschiebungen wenden Sie sich bitte an die Leitstelle Poliklinik +41 61 704 12 20
Mahnung / Inkasso
Patientenabrechnung
Bitte kontaktieren Sie mich
Sonstiges
Dr. med. Felicitas Bellutti Enders
Ausbildung
| 2018 | Swiss Board Certification in Clinical Immunology and Allergy |
| 2017 | Doctor of Philosophy, Utrecht, The Netherlands, Laboratory of Translational Medicine, Prof. Berent Prakken “Juvenile Dermatomyositis: Coloring the grey area” |
| 2012 | Swiss Board Certification in Pediatrics |
| 2011 | University Diploma of Pediatric Rheumatology, Paris and Lyon, France |
| 2009 |
MD degree, University of Lausanne, Switzerland |
| 2001 - 2006 |
University of Medicine, Vienna, Austria |
| 2005 - 2006 |
University of Lausanne, Lausanne, Switzerland |
Beruflicher Werdegang
| Since 2018 |
University Children’s Hospital Basel, Switzerland |
| 2018 – 2019 |
University Hospital Basel, Switzerland |
|
July 2022 - |
University Children’s
Hospital Zürich, Switzerland |
| May 2018 - March 2019 |
University Hospital
Basel, Switzerland |
| 2015 – 2018 |
Department of Allergy and
Immunology and Unit of Pediatric Rheumatology, Immunology and Allergy, CHUV, Lausanne,
Switzerland |
| 2012 – 2014 |
Department of Pediatric Immunology, Wilhelmina Children’s Hospital, Utrecht, The Netherlands |
| 2008 - 2014 |
Departments of Pediatrics
in Yverdon-les-Bains, Aigle and Lausanne (CHUV), Switzerland and Utrecht, The
Netherlands
|
| 2006 –2008 |
Department of Immunology and Allergy, CHUV, Lausanne, Switzerland |
Institutionelle Verantwortlichkeiten
| Since May 2019 | Responsible for the outpatients clinics of pediatric allergy, Hospital of Jura, Delémont, Switzerland |
| Since May 2018 | Responsible for the outpatients clinics of pediatric allergy, University Children’s Hospital Basel, Switzerland |
| Since 2018 | Education of junior residents in pediatrics and clinical immunology and Allergy, University Hospital Basel, University Children’s Hospital Basel Switzerland, University Children’s Hospital Zürich Swizerland |
| 2015-2018 | Education of junior residents in pediatrics and clinical immunology, University Hospital Lausanne, Switzerland |
| 2014 | Supervision of research internship, medical students, University Children’s Hospital, Utrecht, The Netherlands |
Genehmigte Forschungsprojekte
| 2019 | Potential prognostic value of blood cytokine profile, skin and stool microbiome in children with food allergies, University Children’s Hospital, Basel |
| 2015 | Role of Wiskott-Aldrich Protein in Immune Regulation, Department of Immunology, University Hospital Lausanne, Switzerland |
| 2012 | “Regulation of T helper cell subsets in Juvenile Dermatomyositis and their consequences“; Department of Pediatric Immunology, Wilhelmina Children’s Hospital, Utrecht, The Netherlands |
| 2012-2015 | Inflammatory mediators in Juvenile Dermatomyositis: quest for molecular diagnostics, Department of Pediatric Immunology, Wilhelmina Children’s Hospital, Utrecht, The Netherlands (Co-Applicant) |
Betreuung von Nachwuchsforschenden auf Graduierten- und Postgraduiertenebene
| Since 2023 | Ruben Pollak, medical doctor: Supervision of MD thesis “Influence of oral Immunotherapy on quality of life in children |
| Since 2022 | Maria Breiding, medical doctor: Supervision of MD thesis “Oral Immunotherapy for cashew nut and peanut allergy in children 2018-2022 – a retrospective single-center study” |
| Since 2021 | Muriel D’Aujourd’hui, medical student: Supervision of MD thesis “Longitudinal tracking of gut and skin microbioma in children with food allergy” |
| Since 2021 | Manuela Bozic, medical student: Supervision of master thesis “ Evaluation of milk and egg ladder in daily practice” |
| 2015-2017 | Elettra Santori, PhD student: Supervision of the 5th chapter of her PhD thesis “Investigation of the role of WASP in the differentiation of T cells using the human induced pluripotent stem cell system” |
| 2014 | Natanja Oostenroom, medical student: Supervision of her research internship, developing research project, introduction into the field of basic research, and supervision of writing her final report |
Verantwortlichkeiten in der Lehre
| Since 2015 | Training of medical students and junior residents in pediatrics, clinical immunology and allergy, as well as regular lecturer, University Hospital Lausanne, University children’s Hospital Basel, University Switzerland |
|
|
|
Mitgliedschaften in Gremien, Ausschüssen und individuelle wissenschaftliche Begutachtung
| Since 2023 | President of the Society of Pediatric Allergists and Immunologists, position
of secretary 2019-2023 Member of the EAACI working group “Food allergy” |
| Since 2019 | Responsible for training course in Basel “ Anaphylaxis” for parents and families together with the Allergy Center Switzerland (AHA) |
Mitgliedschaften in wissenschaftlichen Vereinigungen
| Since 2017 | Society of Swiss Pediatric Allergists and Immunologists |
| Since 2012 | Swiss Society of Pediatrics |
Preise, Auszeichnungen, Stipendien
| 2020 | Research Fellowship (Forschungsfonds): University of Basel, Switzerland (50.000 CHF) |
| 2019 | Research
Fellowship: Freie Akademische Gesellschaft, Basel, Switzerland (45.000 CHF) |
| 2019 | Antelope Medical Professorship, Career Program, University of Basel, Switzerland (7000 CHF) |
| 2015-2017 | Research Fellowhip: Fondation Machaon, Geneva, Switzerland 2015-2017
(200.000 CHF) |
| 2014 | Research Fellowhip: Fondazione Valeria e Ettore Rossi, Bern,
Switzerland (40.000 CHF) |
| 2013 | Grant for Participating at Eureka Course of Translational Medicine (3800
CHF) |
| 2012-2014 | Research Fellowship: Fond de Perfectionnement, University Hospital Lausanne, Switzerland, (44.000 CHF) Research Fellowhip: Societé Academique Vaudoise, Switzerland (10.000 CHF) Research Fellowship: Fondation SICPA, Switzerland (21.000 CHF) |
Veröffentlichungen (Peer reviewed) in internationalen wissenschaftlichen Zeitschriften (*Erstautor, gemeinsamer Erstautor oder Letztautor)
2024 | Course of growth and nutritional status in Swiss children with food allergies, Gerber R, Meichtry A., van der Horst K. Koehli A., Roduit C., Bellutti Enders F., Skypala I., Hickson M., Eisenblaetter J., Allergo Journal International IF (2023): 2.61. Rank 114/211 |
2022 | Alpha-gal syndrome initially misdiagnosed as chronic spontaneous urticaria in a pediatric patient: a case report and review. Bellutti Enders F., Elkuch M., Wörner A. Scherer Hofmeier K, Hartmann K. Journal of Medical Case Reports, 12/2022, IF (2022): 0.885.* |
2021 | Immune deficiency, autoimmune disease and intellectual disability: A pleiotropic disorder caused by biallelic variants in the TPP2 gene. Atallah, I.,Quinodoz M., Campos-Xavier B., Peter VG., Fouriki A., Bonvin C., Bottani A., Kumps C., Angelini F, Bellutti Enders F., Christen-Zaech S, Rizzi M, Renella R, Beck-Popovic M., Poloni C., Frossard V, Blouin JL., Rivolta C., Riccio O., Candotti F., Hofer M., Unger S., Superti-Furga A., June 2021, Clinical Genetics. IF (2019): 3.578, Rank (2019): 58/178 |
2020 | Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities, Manjaly Thomas ZR., Leupi-Taegtmeyere A., Jamiolkowski D., Steveling-Klein E., Bellutti Enders F., Scherer Hofmeier K., Hartmann K. July 2020, Journal of Clinical Immunology. IF (2019) 10.2, Rank (2019)1/28 |
2019 | Galectin-9 and CXCL-10 as biomarkers for disease activity in juvenile Dermatomyositis: a longitudinal cohort study and multi-cohort validation, Wienke J., Bellutti Enders F. , Lim J. Mertens JS. van den Hoogen L, Wijngaarde C., Yeo JG., Meyer A., Otten HG., Fritsch-Stork RDE., Kampuis SSM., Hoppenreijs EPAH., Armbrust W., van den Berg M., Hissink Muller PCE., Tekstra J, Hoogendijk JE., DEakin CT., de Jager W., van Roon JAG, van der Pol LW., Nistala K., Pilkington C., de Visser M., Arkachaisri T., Radstake TRDJ, van der Kooi AJ., Nierkens S., Wedderburn LR., van Royen-Kerkhof A., van Wijk F. Arthritis&Rheumatology March 2019. Commented in Nature Review Rheumatology March 2019, IF (2019): 9.586, Rank (2019) 3/32 |
| Improve the translational medicine process: Moving patients from “end-users” to “engaged collaborators, Battaglia M., Furlong P., Wulffraat NM., Bellutti Enders F. May 2019, Frontiers of Medicine. IF (2019): 3.113, Rank (2019) 121/244 |
2016 | Consensus-based recommendations for the management of juvenile dermatomyositis, Bellutti Enders F., Bader-Meunier B., Baildam E., Constantin T., Dolezavola P., Feldman BM., Lahdenne P., Magnusson B., Nistala K., Ozen S., Pilkington C., Ravelli A., Russo R., Uziel Y., van Brussel M., van der Net JJ, Vastert S., Wedderburn LR, Wulffraat N, McCann LJ., van Royen-Kerkhof A. Annals of Rheumatic Diseases, August 2016. IF (2016) 12.811. Rank (2016) 1/30 Felicitas Bellutti Enders1,2, Brigitte Bader-Meunier3, Eileen Baildam4, Tamas Constantin5, Pavla Dolezalova6, Brian M Feldman7, Pekka Lahdenne8, Bo Magnusson9, Kiran Nistala10, Seza Ozen11, Clarissa Pilkington |
2014 | Autologous stem cell transplantation leads to a change in proinflammatory plasma cytokine profile of patients with Juvenile Dermatomyositis correlating with disease activity,Bellutti EndersF., DelemarreE. M., Kuemmerle-Deschner J., van der TorreP., Wulffraat N. , Prakken B., van Royen-KerkhofA. and van Wijk F., Annals of Rheumatic Diseases, September 2014. IF (2014) 10.377, Rank (2014): 1/32 |
| Increased presence of FOXP3+ regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis. Vercoulen Y., Bellutti Enders F., Meerding J., Plantinga M., Elst EF., Varsani H., van Schieveen C., Bakker M., Klein M., Scholman RC., Spliet W., Ricotti V., Koenen HJPM., de Weger, Wedderburn LR., van Royen- Kerkhof A., Prakken BJ., PlosOne, August 2014. IF (2014) 3.324, Rank (2014) 9/57 |
| CXCL10, TNFR2 and Galectin-9 correlate with disease activity in Juvenile Dermatomyositis. Bellutti Enders F., F. van Wijk F., Scholman R., Hofer M., Prakken BJ., van Royen-Kerkhof A., and de Jager W. Arthritis&Rheumatology August 2014. Impact factor (2015): 6.009, Rank (2014): 31/32 |
2013 | Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-Specific CD8 T cells, Vigano S., Bellutti Enders F., Miconnet I., Cellerai C., Savoye A.-L., Rozot V., Perreau M., Faouzi M., Ohmiti K., Cavassini M., Bart PA., Pantaleo G., Harari A., PloS Pathog, July 2013. IF (2013) 8.053, Rank (2013) : 10/119 |
| Lack of Mycobacterium tuberculosis-Specific Interleukin 17A–Producing CD4 T Cells in Active Disease, Perreau M., Rozot V., Welles H.C., Bellutti Enders F., Vigano S., Maillard M., Dorta G., Mazza-Stalder J., BartPA, RogerT, CalandraT., Nicod L., Harari A., Eur. J. Immunol, April 2013. IF (2013) 4.518, Rank (2013): 29/144 |
2012 | NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients, Harari A, Rozot V, Cavassini M, Bellutti Enders F, Vigano S, Tapia G, Castro E, Burnet S, Lange J, Moog C, Garin D, Costagliola D, Autran B, Pantaleo G, Bart PA., Eur J Immunol November 2012. IF (2012) 4.97, Rank (2012): 26/137 |
2011 | Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Harari A, Rozot V., Bellutti Enders F., Perreau M., Stalder JM., Nicod LP., Cavassini M., Calandra T., Blanchet CL., Jaton K., Faouzi M., Day CL, Hanekom WA., Bart PA., Pantaleo G., Nature Medicine, March 2011. IF (2011) 22.462, Rank (2011): 3/290 |
2010 | Proliferation capacity and cytotoxic activity are mediated by functionally and phenotypically disticnt virus-specific CD8 T cells defined by interleukin-7R α (CD127) and perforin expression. Cellerai C., Perreau M., Rozot V., Bellutti Enders F., Pantaleo G., Harari A.,Journal of Virology. April 2010. IF (2010) 5.189, Rank (2013): 5/33 |
2009 | *Distinct Profiles of Cytotoxic Granules Correlate with Function and Differentiation Stage of Virus-Specific Memory CD8 T-Cells, Harari A., Bellutti Enders F., Cellerai C., Bart PA., Pantaleo G. Journal of Virology. April 2009. Highlighted as research article with significant interest. IF (2009) 5.15, Rank (2009): 4/30 |
2007 | Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Harari A., Cellerai C., Bellutti Enders F., Köstler J., Codarri L., Tapia G., Boyman O., Castro E., Gaudieri S., James I., John M., Wagner R., Mallal S., Pantaleo G.. Proceedings of the National Academy of Science USA, October 2007. IF (2007) 9.6, Rank (2007): 3/50 |
Mündliche Beiträge zu nationalen und internationalen Konferenzen
| Since 2019 |
Regular presentations at the PAEDART and Refresh Pediatrics/Allergy, national conference for pediatricians (Basel, Zürich): |
| 2013 | CXCL10, TNFR2 and galectin-9 correlate with disease activity in Juvenile Dermatomyositis. Bellutti Enders F., van Wijk F., Scholman R., M. Hofer M., Prakken BJ., van Royen-Kerkhof A., and de Jager W.Pediatric rheumatology European society (PRES) meeting |
| 2011 | Juvenile Dermatomyositis in Western Switzerland.Bellutti Enders F., Hofer M., Annual meeting of Swiss Society of Pediatrics. |
| 2008 | Relationship between degranulation activity and content of granules in virus-specific CD8 T-cells. Bellutti Enders F, Harari A, Cellerai C, Bart PA, Pantaleo G. Annual Meeting of the Swiss Society of Allergy and Immunology. |
Konferenzbeiträge (peer reviewed)
| 2024 | Characterization of the skin and gut microbiome over time in children aged < 3 years with IgE-mediated food allergy. Michèle S. Roth M., Künstner A, Hirose M., Hartmann K., Roduit C., Busch H, Bellutti Enders F. Annual meeting of European Society of Allergy and Clinical Immunology |
| 2023 | Oral Immunotherapy for cashew nut and peanut allergy in children 2018-2022 – a retrospective single-center study, Breiding M, .., Bellutti-Enders F, Annual meeting of European Society of Allergy and Clinical Immunology |
| 2022 | Clinical evaluation of milk and egg ladder programme in cow’s milk and egg allergic children in Basel, Switzerland; Bozic M., .., Bellutti Enders F, Annual meeting of Swiss Society for Allergy and Immunology, August 2022 |
| 2019 | When alpha-Gal syndrome hides behind chronic spontaneous urticarial, Bellutti Enders F., Elkuch M., Wörner A., Scherer-Hofmeier K., Hartmann K., Pediatric Allergy and Asthma Meeting (PAAM) |
| 2016 | Galectin-9, CXCL10 and TNFRII, biomarkers for disease activity in juvenile dermatomyositis, are myositis specific and may reflect highly activated endothelium.Wienke J., Bellutti Enders F., …van Royen-Kerkhof A., Femke van Wijk F., Pediatric Rheumatology European society (PRES) meeting |
| 2015 | Galectin-9 is a robust biomarker for disease activity in juvenile dermatomyositis and acts as a T cell activator. Bellutti EndersF., Wienke J., ...van WijkF. First International Conference on Myositis |
| 2014 | Share – Workpackage 5: Evidence Based Recommedations for Diagnosis and Treatment of Juvenile Dermatomyositis. Bellutti Enders F., …, van Royen-Kerkhof A., Pediatric Rheumatology European society (PRES) meeting CXCL10, TNFR2 and galectin-9 correlate with disease activity in Juvenile Dermatomyositis. Bellutti Enders F. , …, and de Jager, Annual Meeting of Federation of Clinical Immunology (FOCIS) |
| 2012 | Case report: Raynaud’s phenomenon with oral manifestation in a child presenting mixed connective tissue disease. Bellutti Enders F., Hofer M., Pediatric Rheumatology European society (PRES) meeting |
| 2011 | Juvenile Dermatomyositis in Western Switzerland. Bellutti Enders F., Hofer M., Pediatric Rheumatology European society (PRES) meeting |
| 2010 | Salmonella enteriditidis hip infection in a healthy child. A case report. Mauerhofer A., Bellutti Enders F., Paccaud D., Diebold P., Akiki A.,Annual meeting of the Swiss Society of Pediatrics |
Beiträge zu nationalen Leitlinien
| 2024 | Orale Immuntherapie bei Nahrungsmittelallergien: Praktische Empfehlungen für das Patientenmanagement in der Schweiz, Paediatrica |
| 2023 | Kinder mit Atemwegsallergien – Empfehlungen zur Immuntherapie, Swiss Medical Forum |
Kontakt
Dr. med. Felicitas Bellutti Enders
Leitende Ärztin Allergologie
Forschung
Publikationen via Pubmed
Notfälle
Beratungstelefon
für
Kinder- und Jugendnotfälle
0900 712 712 (3.23 CHF/Min., nur über private Festnetz- oder Handynummern)
0900 712 713 (3.23 CHF/Min., für Anrufe von Prepaid-Handys)
0800 444 333 (Abrechnung via Krankenkasse, für Business-Anschlüsse)
Notfall im Ausland
Bei Notfällen im Ausland rufen Sie die Notfallnummer Ihrer Kranken-kasse an. Diese finden Sie jeweils auf Ihrer Krankenkassenkarte.
Tox Info Suisse
(Gift- und Informationszentrum)
145
Kontakt
Universitäts-Kinderspital beider
Basel, Spitalstrasse 33
4056 Basel | CH
Tel. +41 61 704 12 12
Kontaktformular
Kontakt
Universitäts-Kinderspital beider
Basel, Spitalstrasse 33
4056 Basel | CH
Tel. +41 61 704 12 12
Kontaktformular
© UKBB, 2024